The credit rating agency reaffirms the A1+ rating for the Commercial Paper Programme of the company.
Oxemia (Desidustat) is a breakthrough treatment for Anemia associated with Chronic Kidney Disease (CKD) in Patients either on Dialysis or Not on Dialysis.
The centre launches with India’s largest convention centre and the Fountain of Joy dedicated to the city of Mumbai.
A bordering strength in the US Dollar index also dragged the rupee lower.
The weak market sentiments, especially in the wake of the Ukraine-Russia war, have been a dampener for the IPO.
Hindustan Copper and Vedanta were also in the fast lane amid raging copper and aluminium prices.
The bid project cost is Rs636.98 crore and the estimated completion period is 24 months.
Company stated that the total estimated Capital Expenditure for this new facility will be approximately Rs22 to Rs24 crore which shall be contributed through internal accruals.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
